Aaron Kantoff, Director at Tourmaline Bio, Inc. (TRML), bought 7,500 shares at $11.86 ($89K) on 2023-10-24, disclosed to the SEC on 2023-10-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.